Agranulocytosis while receiving combined reserpine-chlorpromazine therapy; report of two cases.
D000380:Agranulocytosis / Q000209:etiology*; D002746:Chlorpromazine / Q000009:adverse effects*; D001523:Mental Disorders / Q000628:therapy*; D011612:Psychosurgery; D011613:Psychotherapy; D011616:Psychotherapy, Multiple; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000009:adverse effects*
D046948:Secologanin Tryptamine Alkaloids; D012110:Reserpine; D002746:Chlorpromazine
AGRANULOCYTOSIS/etiology and pathogenesis; CHLORPROMAZINE/injurious effects; MENTAL DISORDERS/therapy; RAUWOLFIA ALKALOIDS/injurious effects